Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Australia
/
Pharmaceuticals & Biotech
Create a narrative
Vita Life Sciences Community
ASX:VLS Community
1
Narratives
written by author
0
Comments
on narratives written by author
28
Fair Values set
on narratives written by author
Create a narrative
Vita Life Sciences
Latest
Undervalued
Overvalued
Community Investing Ideas
Vita Life Sciences
RO
Robbo
Community Contributor
Vita Life Sciences Set for a 12.72% Revenue Growth While Tackling Operational Challenges
Vita Life Sciences (ASX: VLS) – A Solid Business Seeking Renewed Momentum Vita Life Sciences (ASX: VLS) is a well-established healthcare company specializing in the formulation, packaging, distribution, and sale of vitamins and supplements across the Asia-Pacific region. Founded in 1947, the company boasts strong brand recognition through its labels such as VitaHealth, Herbs of Gold, VitaScience, and VitaLife, offering over 350 premium healthcare and pharmaceutical products.
View narrative
AU$2.42
FV
8.7% undervalued
intrinsic discount
12.72%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
20
users have followed this narrative
15 days ago
author updated this narrative
Your Valuation for
VLS
VLS
Vita Life Sciences
Your Fair Value
AU$
Current Price
AU$2.21
27.5% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
150m
2015
2018
2021
2024
2025
2027
2030
Revenue AU$150.3m
Earnings AU$16.6m
Advanced
Set Fair Value